# Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS

> **NCT07461545** · NA · RECRUITING · sponsor: **Northern Jiangsu People's Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Cirrhosis
- Splenectomy
- Portal Vein Thrombosis
- Hypertension, Portal

## Interventions

- **DRUG:** Apixaban 2.5 MG

## Key facts

- **NCT ID:** NCT07461545
- **Lead sponsor:** Northern Jiangsu People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07461545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07461545, "Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07461545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*